12. April 2023 | Corporate News

Marinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever

  • Carragelose nasal spray shows significant effectiveness in the prophylactic treatment of allergic rhinitis symptoms in the nose
  • Clinical data extend the effectiveness of Carragelose from blocking respiratory viruses to pollen and further prove the barrier function of the product
  • The expansion of the use of Carragelose products from the cold to the allergy season will continue to drive further business growth

 

The full press release is available as download here: 

Marinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever
(60 KB)